EUROPEAN COMMISSION APPROVES CRYSVITA® (BUROSUMAB) FOR INFANTS WITH X-LINKED HYPOPHOSPHATAEMIA IN THE EUROPEAN UNION

Reuters · 2d ago

Please log in to view news